Antibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign? | Zendy

Seydou Yaro | Zendy; Berthe-Marie Njanpop Lafourcade | Zendy; Soumeya Ouangraoua | Zendy; Aline Raissa Ouoba | Zendy; Hervé Kpoda | Zendy; Helen Findlow | Zendy; Haoua Tall | Zendy; Joy Seanehia | Zendy; Catherine Martin | Zendy; JeanBosco Ouédraogo | Zendy; Bradford D. Gessner | Zendy; Nicolas Méda | Zendy; Ray Borrow | Zendy; Caroline Trotter | Zendy; Judith E. Mueller | Zendy

Open Access

Antibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign?

Author(s) -

Seydou Yaro,

Berthe-Marie Njanpop Lafourcade,

Soumeya Ouangraoua,

Aline Raissa Ouoba,

Hervé Kpoda,

Helen Findlow,

Haoua Tall,

Joy Seanehia,

Catherine Martin,

JeanBosco Ouédraogo,

Bradford D. Gessner,

Nicolas Méda,

Ray Borrow,

Caroline Trotter,

Judith E. Mueller

Publication year - 2018

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciy488

Subject(s) - vaccination , conjugate vaccine , meningococcal vaccine , medicine , persistence (discontinuity) , serology , booster (rocketry) , mass vaccination , booster dose , population , virology , antibody , immunology , immunogenicity , immunization , environmental health , physics , astronomy , geotechnical engineering , engineering

In Burkina Faso, serogroup A meningococcal (NmA) conjugate vaccine (PsA-TT, MenAfriVac) was introduced through a mass campaign in children and adults in December 2010. Similar to a serological survey in 2011, we followed population-level antibody persistence for 5 years after the campaign and estimated time of return to previously-published pre-vaccination levels.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research